Clinical Trials in Georgia

Showing 8221-8240 of 19,050 trials

The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2

NCT04313023

Subjects who have documented exposure to SARS-CoV-2 (COVID-19) will receive 4 doses of PUL-042 Inhalation Solution or 4 doses of a placebo solution by inhalation over 10 days. Subjects will be followed for the incidence and severity of COVID-19 over 28 days. Subjects will be tested for infection with SARS-CoV-2 at the beginning, middle and end of the study.

COVID-19

Pulmotect, Inc.217 participantsStarted Jun 2020

Orange, California, United States • San Bernardino, California, United States • Coral Gables, Florida, United States +12 more locations

COMPLETEDPhase 365 miles

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

NCT02600507

The study will evaluate the efficacy and safety of ITI-007 adjunctive to lithium or valproate in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.

Bipolar Depression

Intra-Cellular Therapies, Inc.529 participantsStarted Mar 2016

Rogers, Arkansas, United States • Cerritos, California, United States • Costa Mesa, California, United States +68 more locations

The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

Find Trials by Condition in Georgia

Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)

Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis

A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy

Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects

P3 Long Term Safety Study of Once Daily SB204 in Acne

rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study

Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception

Effectiveness of Early Intervention in an Underserved Population

A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

Glycemic Control and the Brain in Children With Type 1 Diabetes

GalaFlex Mesh in Facelift

Study to Evaluate the Effect of a Single Oral Dose of MT-7117 on the QT/QTc Interval in Healthy Subjects

PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis

Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy

First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer

HBV-HIV Coinfection Research Network